Menopause represents one of the most clinically complex transitions in women’s health. It’s also one of the fastest-growing treatment categories across the telehealth landscape.
As patient demand for personalized hormone care increases, providers are evaluating compounded formulation options that standard commercial products cannot accommodate.
BHRT therapy protocols offer a degree of customization. They position telehealth companies to serve a broader range of menopausal patient presentations.
This article outlines the clinical framework behind BHRT, the hormones involved, candidacy considerations, and how compounding pharmacies support scalable fulfillment for women’s health protocols.
What Is Bioidentical Hormone Replacement Therapy (BHRT)?
Providers researching bioidentical hormones pros and cons typically begin with the molecular distinction between bioidentical and synthetic formulations
Bioidentical hormones are structures that mimic those of human steroid hormones. These substances are derived from plant oils through a chemical conversion process to the plant.
The products are a match in structure and function of endogenous hormones in the human body. They’re also made available for professional compounding.
Bioidentical hormone replacement therapy (BHRT) aims to restore balance between hormone levels and can alleviate the symptoms of menopause. Unlike synthetic hormone formulations, bioidentical compounds are molecularly identical to the hormones the body produces naturally.
Understanding what is BHRT ultimately starts at the molecular level. This is why providers evaluating hormone replacement therapy options increasingly distinguish between commercial and compounded formulations when building menopause protocols.
How Menopause Affects Hormone Levels
Menopause is a permanent cessation of menstruation resulting from loss of ovarian function. A patient may be classified as menopausal if it has been at least 12 months since their last menstrual cycle.
During menopause, there are significant changes in hormone levels which can result in symptoms that negatively affect a woman’s quality of life. Such symptoms include hot flashes, night sweats, and sleep disturbances.
The hormone levels affected during the menopausal period are those of estrogen, progesterone, and testosterone. When the ovaries fail, overall estrogen levels fall.
Likewise, after age 35 years, progesterone levels decline as the ovaries begin to deteriorate and continue to fall after menopause. Testosterone gradually declines with age as well as its precursor DHEA, particularly in patients who are stressed.
For telehealth companies building out women’s health protocols, understanding this hormonal cascade is foundational. Bioidentical hormones for menopause are compounded to address these specific deficiencies across the full spectrum of symptom presentations.
Which Hormones Does BHRT Target?
The goal of BHRT is to regain the balance of these endogenous hormones utilizing the compounded substances which mimic them. Each of these hormone deficiencies affect specific symptoms that the bioidentical hormones target to treat.
- Estrogen: hot flashes, night sweats, decreased libido, vaginal dryness, vaginal atrophy, irritability
- Progesterone: PMS, mood swings, insomnia, foggy thinking
- Testosterone/DHEA: decreased libido, decreased metabolism, low energy
A commonly compounded estrogen formulation in this category is Biest, a combination of estradiol and estriol, which allows prescribers to adjust the ratio of each estrogen fraction based on individual patient response. Biest illustrates the clinical flexibility that compounded BHRT therapy makes possible compared to fixed-ratio commercial alternatives.
Who Is a Candidate for Compounded BHRT
Evaluating candidacy for BHRT therapy requires a multi-factor clinical assessment. Important factors to consider whether a woman is a candidate for BHRT include medical history, current medications, hysterectomy status, and assessment of hydration and stress level.
Labs are used to guide target symptoms to treat since they can indicate which imbalances exist. To detect hormone deficiencies, a saliva test is utilized to measure the unbound hormones through saliva capillaries.
This is the preferred method as it is easily collected and correlates with serum levels. A thorough understanding of bioidentical hormones pros and cons informs which patients are most likely to benefit from compounded protocols versus commercial alternatives.
BHRT for women is not a uniform protocol since candidacy is determined through a multi-factor clinical assessment. Providers should also consider AI in telehealth tools increasingly used to support patient intake and symptom triage in hormone health platforms, since these are reshaping how candidacy data is collected at scale.
Why Compounded BHRT vs. Commercial HRT?
The question of BHRT vs HRT is one telehealth formulary teams encounter early when building menopause protocols.
As opposed to commercially available HRT, compounded BHRT allows patient-specific needs to be met with various combinations that can be individually determined in a range of available dosage forms. This can be beneficial for women who may not tolerate FDA approved products or the ingredients contained in them.
The distinction between BHRT vs HRT is a central formulary consideration. When evaluating bioidentical hormones pros and cons relative to conventional HRT, the primary clinical advantage of compounding is individualization.
A related consideration is the role of active ingredients and potency verification since USP 795-compliant facilities follow documented standards for ingredient sourcing and formulation accuracy that directly affect clinical outcomes. Boric Acid Suppositories are also frequently part of the broader compounded women’s health formulary alongside BHRT.
Understanding the difference between BHRT vs HRT at the formulation level is essential for providers making evidence-based prescribing decisions.
Available Dosage Forms Through Compounding
Compounded BHRT therapy is available across a wide range of delivery formats, allowing prescribers to select the route most appropriate for each patient’s presentation.
Available dosage forms include:
- Capsules (immediate release and slow release)
- Vaginal creams and suppositories
- Transdermal and topical gels
- Troches and rapid-dissolve tablets (RDTs)
- Nasal sprays
- Sublingual tablets
Delivery format flexibility is a defining advantage of compounded BHRT for menopause. It’s often the case for patients who have discontinued commercial HRT due to tolerability issues with a specific route.
Ultimately, bioidentical hormones pros and cons are often evaluated in tandem with delivery format. This is because the route of administration affects both absorption and patient adherence.
Partnering With a Compounding Pharmacy for BHRT Fulfillment
Telehealth companies expanding into hormone health need a fulfillment partner with demonstrated compounding depth across the full BHRT formulary. One that spans non-sterile forms such as creams, capsules, and suppositories, as well as longevity-adjacent compounds.
A pharmacy operating under USP 795 standards with NABP accreditation and broad state licensure provides the compliance infrastructure that hormone health platforms require.
Precision Medicine supports telehealth companies through white label fulfillment and functions as a behind-the-scenes compounding partner that dispenses under your brand. BHRT therapy protocols can be fulfilled across a range of formulations without requiring telehealth companies to manage pharmacy operations directly.
For platforms evaluating custom formulas beyond standard formulary offerings, including specific hormone ratios, novel delivery formats, or combination compounds, Precision Medicine’s compounding capabilities are available through direct partnership inquiry.